A 2022 systematic review published in Frontiers in Psychiatry explores the molecular underpinnings of ketamine’s…
Read More
New clinical data confirm that safe, low-cost ketamine is not only effective but also well-tolerated…
A recent active-controlled trial using subcutaneous ketamine injections over four weeks has demonstrated strong efficacy…
A new large-scale trial conducted by researchers at the University of New South Wales (UNSW)…
A groundbreaking clinical trial published in the New England Journal of Medicine (NEJM) has reignited…
Major depressive disorder (MDD) continues to be a leading cause of disability worldwide, affecting over…
In the clinical study Efficacy of ketamine therapy in the treatment of depression by Mandal,…
In the systematic review and meta-analysis Ketamine as a Novel Treatment for Major Depressive Disorder…
In the landmark study A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients…
In the open-label clinical study Efficacy, safety, and durability of repeated ketamine infusions for comorbid…
